Global Tetanus Toxoid Vaccine Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: May 5, 2021 |

The global tetanus toxoid vaccines market size is anticipated to register a significant CAGR of 4.7% during the forecast period and estimated to reach USD 6,601 million by 2027. The rising prevalence of Clostridium tetani infection in the developing regions primarily drives the tetanus toxoid vaccines market growth. Furthermore, recent advancement in the technology transfer process regarding the development of polyvalent vaccines provide positive impetus to the market growth.

Tetanus is an infectious disease which is caused by the bacterium Clostridium tetani, which affects the central nervous system resulting in lockjaw and muscle stiffness, difficulty in breathing and eventually causes death if not treated early. As per the latest research citings provided by the World Health Organization (WHO), in 2017 approximately 38,000 people worldwide died due to the tetanus infection. Further in depth analysis provide vital information regarding the clinical manifestation of tetanus infection which are headache, seizures, sweating, fever, muscle spams etc.

Market Segment Insights:

Polyvalent vaccines are representing the largest market share in the types segment for tetanus toxoid vaccines market. Frequent skin laceration by rusted utensils, tools and repeated exposure to contaminated surface such as soil, animal and human feces etc. causes the transmission of the Clostridium tetani bacteria in human beings. It is available in different combination such as diphtheria, tetanus, and pertussis (DTaP) and Diphtheria and Tetanus (DT) which are mentioned in the compulsory immunization program for newborn babies worldwide. Monovalent vaccines are going to showcase steady market growth during the forecast period as growing incidence of clostridium tetani infection in the middle and low income countries primarily drives the monovalent vaccines market growth. It is given to adult population who have never received a tetanus vaccines during their childhood and thus monovalent vaccine is given to develop a strong immune response.

Tetanus Toxoid Vaccines Market Size & CAGR

For more insights about the study, request a report sample

Hospitals are currently leading the end user segment for tetanus toxoid vaccines market. Compulsory immunization of tetanus toxoid vaccines in the children throughout the globe has resulted in significant increase in the number of inpatient visits to the primary healthcare centers worldwide. Proactive initiative adopted by Government healthcare agencies to provide free vaccines to government sponsored hospitals to encourage the immunization program further consolidate the market growth. Specialty clinics are expected to register rampant market growth in the near future owing to the increasing disposable income in middle income families, which frequently visit specialty clinics for immunization of children’s at affordable price.

Global tetanus toxoid vaccines market size and forecast were obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.

The tetanus toxoid vaccines market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Tetanus Toxoid Vaccines Market Segmentation:

By Type:

  • Monovalent
  • Polyvalent

By End-User:

  • Hospitals
  • Specialty Clinics
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

North America is presently dominating the geography segment for tetanus toxoid vaccines market. Mandatory immunization of children as per the vaccination guidelines provided by the USFDA primarily drives the tetanus toxoid vaccines market growth. Existence of well-established healthcare infrastructure and affordable reimbursement scenario associated with immunization programs further accentuate the market growth in the region. Europe is placed in the second position in the regional segment owing to the domicile of major players such as Merck & Co. Inc., Sanofi Pasteur, GlaxoSmithkline, Plc. etc determine the market growth in the region. Asia Pacific is anticipated to be the fastest growing regional segment for tetanus toxoid vaccines market. Rising incidence of Clostridium tetani infection determines the market growth in the region. Emergence of local players and developing healthcare infrastructure further bolster the market growth in the Asia Pacific region.

Market Competition Assessment:

Key players operating in the global tetanus toxoid vaccines market are Sanofi Pasteur, Merck & Co. Inc., Pfizer, Inc., GlaxoSmithKline, Plc., and Bharat Biotec. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Sanofi Pasteur
  • GlaxoSmithkline, Plc.
  • Merck & Co. Inc.
  • Pfizer, Inc.
  • Bharat Biotec
  • Serum Institute Of India Limited
  • Panacea Biotec Ltd.
  • Astellas Pharma, Inc.
  • Emergent Biosolutions, Inc.
  • PT Bio Farma

Key Questions Answered by Tetanus Toxoid Vaccines Market Report:

  • Global tetanus toxoid vaccines market forecasts from 2021-2027
  • Regional tetanus toxoid vaccines market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Tetanus toxoid vaccines submarket forecasts from 2021-2027 covering the market by type, by end-user, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to tetanus toxoid vaccines market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level tetanus toxoid vaccines markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the tetanus toxoid vaccines market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Tetanus Toxoid Vaccines Market Portraiture
2.2. Global Tetanus Toxoid Vaccines Market, by Type, 2020 (USD Mn)
2.3. Global Tetanus Toxoid Vaccines Market, by End-User, 2020 (USD Mn)
2.4. Global Tetanus Toxoid Vaccines Market, by Geography, 2020 (USD Mn)

 

3. Global Tetanus Toxoid Vaccines Market Analysis


3.1. Tetanus Toxoid Vaccines Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Tetanus Toxoid Vaccines Market By Type, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Monovalent
4.3. Polyvalent

 

5. Global Tetanus Toxoid Vaccines Market By End-User, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Hospitals
5.3. Specialty Clinics
5.4. Others

 

6. North America Tetanus Toxoid Vaccines Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
6.1.3. North America Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
6.1.4. North America Tetanus Toxoid Vaccines Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
6.1.4.1.2. U.S. Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
6.1.4.2.2. Canada Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)

 

7. Europe Tetanus Toxoid Vaccines Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
7.1.3. Europe Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
7.1.4. Europe Tetanus Toxoid Vaccines Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
7.1.4.1.2. Germany Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
7.1.4.2.2. U.K. Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
7.1.4.3.2. France Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
7.1.4.4.2. Italy Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)

 

8. Asia Pacific Tetanus Toxoid Vaccines Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
8.1.3. Asia Pacific Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
8.1.4. Asia Pacific Tetanus Toxoid Vaccines Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
8.1.4.1.2. China Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
8.1.4.2.2. Japan Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)

 

9. Latin America (LATAM) Tetanus Toxoid Vaccines Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
9.1.3. Latin America Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
9.1.4. Latin America Tetanus Toxoid Vaccines Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
9.1.4.1.2. Brazil Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
9.1.4.2.2. Mexico Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)

 

10. Middle East and Africa Tetanus Toxoid Vaccines Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
10.1.3. MEA Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
10.1.4. Middle East and Africa Tetanus Toxoid Vaccines Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
10.1.4.1.2. GCC Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)
10.1.4.2. Rest of MEA
10.1.4.2.1. Rest of MEA Tetanus Toxoid Vaccines Market by Type (2018-2027 USD Mn)
10.1.4.2.2. Rest of MEA Tetanus Toxoid Vaccines Market by End-User (2018-2027 USD Mn)

 

11. Company Profiles


11.1. Sanofi Pasteur
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. GlaxoSmithkline, Plc.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Merck & Co. Inc.
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Pfizer, Inc.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Bharat Biotec
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Serum Institute Of India Limited
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Panacea Biotec Ltd.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Astellas Pharma, Inc.
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Emergent Biosolutions, Inc.
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. PT Bio Farma
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Tetanus Toxoid Vaccine Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to the request, please read our FAQs below)
(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Tetanus Toxoid Vaccine Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients